Passage Bio CEO Will Chou to Share Insights at Guggenheim Healthcare Innovation Conference!

Passage Bio

PHILADELPHIA, PAPassage Bio, Inc. (NASDAQ: PASG) announced that Will Chou, M.D., the president and chief executive officer of the company, will be presenting at the prestigious Guggenheim Securities Healthcare Innovation Conference. This important event is scheduled for Wednesday, November 13, 2024, at 2:30 p.m. ET.

For those unable to attend in person, a live webcast of the presentation will be readily accessible in the Investors & Media section of Passage Bio’s official website at investors.passagebio.com. Additionally, a replay of the presentation will be available for a full 30 days following the event, allowing everyone ample opportunity to catch up on this significant discussion.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  Victor Raymond Tabaac Joins All In On Data as Chief Revenue Officer